BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma

Cancer Immunology, Immunotherapy : CII
Qi LiuLeaf Huang

Abstract

Approximately, 50% of human melanomas are driven by BRAF mutations, which produce tumors that are highly immunosuppressive and often resistant to vaccine therapy. We introduced lipid-coated calcium phosphate nanoparticles (LCP NPs) as a carrier to efficiently deliver a tumor-specific antigen, the BRAFV600E peptide, to drive dendritic cell (DC) maturation and antigen presentation in C57BL6 mice. The BRAF peptide vaccine elicited a robust, antigen-specific cytotoxic T cell response and potent tumor growth inhibition in a murine BRAF-mutant melanoma model. Advanced BRAF-specific immune response was illustrated by IFN-γ production assay and cytotoxic T lymphocyte (CTL) assay. Remodeling of immunosuppressive modules within the tumor microenvironment further facilitated CTL infiltration. Thus, using LCP NPs to deliver the BRAF peptide vaccine is a promising strategy for the BRAF-mutant melanoma therapy.

References

Dec 16, 1983·Journal of Immunological Methods·C C CzerkinskyA Tarkowski
Mar 1, 1996·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·H M Gloster, D G Brodland
Dec 22, 1999·Immunogenetics·H RammenseeS Stevanović
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R MiddletonN Thatcher
May 5, 2000·The Cochrane Database of Systematic Reviews·T CrosbyM D Mason
Sep 15, 2000·CA: a Cancer Journal for Clinicians·D S Rigel, J A Carucci
Apr 16, 2002·Science·Ruslan Medzhitov, Charles A Janeway
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Apr 30, 2003·Protein Science : a Publication of the Protein Society·Morten NielsenOle Lund
Jun 6, 2003·Oncogene·María S Soengas, Scott W Lowe
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M F AvrilY Menu
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Jun 10, 2004·British Journal of Cancer·S BamfordR Wooster
Mar 18, 2005·Annual Review of Immunology·Argyrios N TheofilopoulosDwight H Kono
Jul 11, 2006·Annual Review of Cell and Developmental Biology·Celeste M Nelson, Mina J Bissell
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christine A PratilasNeal Rosen
Nov 19, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jun LiLeaf Huang
Feb 25, 2010·Journal of the National Cancer Institute·Simone MocellinDonato Nitti
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 3, 2011·The New England Journal of Medicine·Douglas J SchwartzentruberPatrick Hwu
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Aug 30, 2011·Accounts of Chemical Research·Xia Guo, Leaf Huang
Mar 23, 2012·Nature Reviews. Immunology·Nicholas P RestifoSteven A Rosenberg
Dec 18, 2012·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Viktor Umansky, Alexandra Sevko
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Sep 6, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhenghong XuLeaf Huang
Sep 21, 2013·Nature·Melissa R Junttila, Frederic J de Sauvage
Sep 30, 2014·The New England Journal of Medicine·Georgina V LongKeith Flaherty
Dec 17, 2014·Frontiers in Chemistry·João ConniotTeresa S Barata
Dec 30, 2014·Trends in Cell Biology·Florian Klemm, Johanna A Joyce
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk SchadendorfJedd D Wolchok
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Sep 4, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yao LuLeaf Huang
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 16, 2016·Nature Reviews. Cancer·Suzanne L TopalianDrew M Pardoll
Sep 13, 2016·The Lancet Oncology·Jessica C Hassel
Jun 19, 2017·Advanced Drug Delivery Reviews·Lei MiaoLeaf Huang

❮ Previous
Next ❯

Citations

Dec 21, 2017·Journal of Drug Targeting·Jia-Lin HuangXiao-Ling Gao
May 30, 2019·Cancer Immunology, Immunotherapy : CII·Sonja LudwigTheresa L Whiteside
Oct 17, 2019·Journal of Cancer Research and Clinical Oncology·Guang YangZai-Shun Jin
Sep 3, 2019·Current Topics in Medicinal Chemistry·Fengqian ChenQi Liu
Dec 5, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Fengqian ChenQi Liu
Sep 27, 2020·Genes·Ilayda AtesRenee N Cottle
Aug 12, 2018·Vaccines·Angelika Terbuch, Juanita Lopez
Oct 10, 2020·Cancer Immunology, Immunotherapy : CII·Karin L LeeDuane H Hamilton
Nov 24, 2020·Journal of Biomolecular Structure & Dynamics·Zahra YazdaniReza Valadan
May 1, 2021·Pharmaceutics·Jeroen HeutsKoen van der Maaden
Aug 9, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bixi SunXiaoshu Gao
Nov 19, 2021·Bioconjugate Chemistry·Ayesha ZafarZhifei Dai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.